TEST:

GynTect®

GynTect® test is developed in order to prevent patients from the stressful period of uncertainty surrounding abnormal cervical cancer screening and follow-up results, and to offer doctors a quick and reliable cervical cancer diagnosis. This non-invasive test, performed from just one cervical smear, examines the DNA of cells for changes that indicate cervical cancer and its preliminary stages. The GynTect assay detects cancer-related changes in DNA methylation from cervical smears. It is designed to provide confirmation or identify a predisposition for cervical cancer in patients with abnormal findings, such as a positive HPV test, from a cervical cancer screen.